Andrea Botticelli Selected Research

Andrea Botticelli Research Topics

Disease

63	Neoplasms (Cancer) 04/2024 - 09/2014
38	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2013
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2018
11	Triple Negative Breast Neoplasms 02/2024 - 03/2018
10	Squamous Cell Carcinoma of Head and Neck 04/2024 - 01/2020
7	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2019
7	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 01/2016
6	Head and Neck Neoplasms (Head and Neck Cancer) 04/2023 - 04/2020
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2018
4	Melanoma (Melanoma, Malignant) 09/2023 - 01/2020
4	Brain Neoplasms (Brain Tumor) 09/2023 - 11/2017
4	Pathologic Complete Response 01/2023 - 01/2019
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2022 - 11/2016
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2020
3	Microsatellite Instability 08/2023 - 04/2021
3	Disease Progression 01/2023 - 12/2017
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 08/2021
3	Colonic Neoplasms (Colon Cancer) 08/2020 - 09/2014
2	Sarcopenia 01/2024 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2020 - 12/2019
2	Overweight 01/2020 - 01/2019
1	Rectal Neoplasms (Rectal Cancer) 04/2024
1	Circulating Neoplastic Cells 08/2023
1	Residual Neoplasm 08/2023
1	Oral Lichen Planus 05/2023
1	Rheumatic Diseases (Rheumatism) 03/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Breakthrough Infections 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Cardiotoxicity 01/2023
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2022
1	Arthritis (Polyarthritis) 01/2022

Drug/Important Bio-Agent (IBA)

27	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2017
16	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2016
9	NivolumabIBA 01/2023 - 04/2018
6	pembrolizumabIBA 04/2024 - 01/2021
6	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 01/2013
6	pertuzumabIBA 01/2023 - 01/2017
6	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 01/2016
5	Trastuzumab (Herceptin)FDA Link 10/2023 - 10/2015
5	PlatinumIBA 10/2022 - 04/2020
5	Cyclin-Dependent Kinase 4IBA 05/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2020
4	Capecitabine (Xeloda)FDA Link 01/2023 - 11/2016
4	Taxoids (Taxanes)IBA 01/2023 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 11/2020
4	Hormones (Hormone)IBA 04/2022 - 01/2019
4	palbociclibIBA 01/2021 - 01/2019
4	Everolimus FDA Link 12/2020 - 01/2017
3	human ERBB2 proteinIBA 11/2023 - 01/2021
3	AnthracyclinesIBA 10/2023 - 05/2018
3	atezolizumabIBA 09/2023 - 09/2020
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2023 - 11/2019
3	cemiplimabIBA 05/2022 - 08/2021
3	ribociclibIBA 01/2022 - 01/2020
3	Monoclonal AntibodiesIBA 12/2021 - 04/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	Ado-Trastuzumab EmtansineIBA 01/2021 - 01/2017
3	exemestane (Aromasin)FDA Link 12/2020 - 01/2017
3	Aromatase InhibitorsIBA 01/2020 - 02/2016
2	Estrogen ReceptorsIBA 10/2023 - 01/2020
2	130-nm albumin-bound paclitaxelIBA 09/2023 - 01/2013
2	Programmed Cell Death 1 ReceptorIBA 07/2023 - 11/2022
2	Phenobarbital (Luminal)FDA Link 11/2022 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2021
2	B7-H1 AntigenIBA 04/2021 - 04/2020
2	Estrogens (Estrogen)FDA Link 03/2021 - 01/2021
2	abemaciclibIBA 01/2021 - 01/2020
2	Opioid Analgesics (Opioids)IBA 01/2021 - 11/2020
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2020 - 08/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2020 - 01/2018
2	LigandsIBA 09/2020 - 01/2020
2	taxaneIBA 01/2019 - 01/2017
2	Floxuridine (FUdR)FDA LinkGeneric 02/2017 - 01/2017
1	Trinitrotoluene (TNT)IBA 04/2024
1	trastuzumab deruxtecanIBA 11/2023
1	Syndecan-1 (Syndecan 1)IBA 09/2023
1	Circulating Tumor DNAIBA 08/2023
1	Nucleic AcidsIBA 08/2023
1	4-azidobenzylcarazolol (pABC)IBA 02/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	VaccinesIBA 01/2023
1	SolutionsIBA 08/2022
1	Dental Implants (Dental Implant)IBA 08/2022
1	Interleukin-13IBA 01/2022

Therapy/Procedure

32	Therapeutics 02/2024 - 02/2016
26	Immunotherapy 09/2023 - 01/2019
17	Drug Therapy (Chemotherapy) 04/2024 - 01/2016
9	Neoadjuvant Therapy 04/2024 - 03/2018
7	Radiotherapy 04/2024 - 11/2017
5	Adjuvant Chemotherapy 04/2024 - 01/2017
2	Induction Chemotherapy 12/2022 - 11/2020
2	Precision Medicine 11/2022 - 07/2021
1	Modified Radical Mastectomy (Mastectomy, Modified) 01/2023
1	Time-to-Treatment 01/2023
1	Prostheses and Implants (Prosthesis) 08/2022
1	Immunomodulation 05/2022
1	Palliative Care (Palliative Therapy) 04/2022